Regencell Bioscience, Duolingo, and Wynn Resorts are the three Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are shares of companies that are incorporated in and primarily operate out of mainland China or the Hong Kong Special Administrative Region. These equities can be traded on domestic exchanges like the Shanghai and Shenzhen Stock Exchanges or externally via the Hong Kong Stock Exchange and overseas markets through instruments such as American Depositary Receipts (ADRs). These companies had the highest dollar trading volume of any Chinese stocks within the last several days.
Regencell Bioscience (RGC)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Shares of RGC traded up $12.63 during mid-day trading on Friday, hitting $22.99. 18,796,157 shares of the company traded hands, compared to its average volume of 1,560,359. Regencell Bioscience has a 1 year low of $0.08 and a 1 year high of $83.60.
Read Our Latest Research Report on RGC
Duolingo (DUOL)
Duolingo, Inc. operates as a mobile learning platform in the United States, the United Kingdom, and internationally. The company offers courses in 40 different languages, including Spanish, English, French, German, Italian, Portuguese, Japanese, and Chinese through its Duolingo app. It also provides a digital English language proficiency assessment exam.
DUOL stock traded down $1.61 during trading on Friday, reaching $395.39. The stock had a trading volume of 552,232 shares, compared to its average volume of 724,368. The stock's 50 day moving average is $477.01 and its two-hundred day moving average is $386.30. Duolingo has a 52 week low of $145.05 and a 52 week high of $544.93. The company has a current ratio of 2.68, a quick ratio of 2.68 and a debt-to-equity ratio of 0.06. The firm has a market cap of $17.97 billion, a PE ratio of 194.78, a PEG ratio of 3.04 and a beta of 0.89.
Read Our Latest Research Report on DUOL
Wynn Resorts (WYNN)
Wynn Resorts, Limited designs, develops, and operates integrated resorts. The company operates through four segments: Wynn Palace, Wynn Macau, Las Vegas Operations, and Encore Boston Harbor. The Wynn Palace segment operates private gaming salons and sky casinos; a luxury hotel tower with suites, and villas, including a health club, spa, salon, and pool; food and beverage outlets; retail space; meeting and convention space; and performance lake and floral art displays.
Shares of WYNN stock traded up $0.84 during mid-day trading on Friday, reaching $105.52. 1,407,270 shares of the company's stock traded hands, compared to its average volume of 2,598,311. The firm has a market capitalization of $11.03 billion, a PE ratio of 29.31, a price-to-earnings-growth ratio of 3.03 and a beta of 1.37. Wynn Resorts has a 12 month low of $65.25 and a 12 month high of $107.81. The firm has a 50 day moving average price of $89.56 and a two-hundred day moving average price of $85.51.
Read Our Latest Research Report on WYNN
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Regencell Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Regencell Bioscience wasn't on the list.
While Regencell Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.